Hyperphosphatemia: Difference between revisions

No edit summary
No edit summary
Line 5: Line 5:
*Decreased excretion ([[Renal failure]]
*Decreased excretion ([[Renal failure]]
*Transcellular shifts ([[Tumor lysis syndrome]], [[Rhabdomyolysis]])
*Transcellular shifts ([[Tumor lysis syndrome]], [[Rhabdomyolysis]])
==Clinical Features==
*Fatigue
*[[Shortness of breath]]
*Anorexia
*[[Nausea]]
*[[Vomiting]]
*Insomnia


==Differential Diagnosis==
==Differential Diagnosis==
Line 20: Line 28:
Symptoms usually related to associated renal failure, [[hypocalcemia]] or [[hypomagnesemia]]
Symptoms usually related to associated renal failure, [[hypocalcemia]] or [[hypomagnesemia]]
*Metabolic Panel (with calcium, Magnesium, and Phosphorus)
*Metabolic Panel (with calcium, Magnesium, and Phosphorus)
===Signs and Symptoms===
*Fatigue
*Shortness of breath
*Anorexia
*Nausea
*Vomiting
*Insomnia


==Management==
==Management==

Revision as of 10:26, 25 October 2016

Background

Major Causes

Clinical Features

Differential Diagnosis

Evaluation

Labs

Symptoms usually related to associated renal failure, hypocalcemia or hypomagnesemia

  • Metabolic Panel (with calcium, Magnesium, and Phosphorus)

Management

Hyperphosphatemia treatment

  • Treat the underlying cause
  • Restrict calcium phosphate intake
  • IV Normal Saline (if normal renal fx)
  • Acetazolamide (500mg IV q6hr) - if normal renal function
  • Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect
  • Dialysis if refractory

References

  1. Hawley C. Serum phosphate. Nephrology. Apr 2006. 11(S1):S201-5.

See Also